Nu Skin Enterprises, Inc.

NUS ·Healthcare, Medical Distribution, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Operating Activities
Net Income $160.2M $-146.6M $8.6M $104.8M $147.3M $191.4M $173.6M $121.9M
Depreciation & Amortization $52.3M $69.8M $70.9M $72.5M $76.3M $74.0M $76.7M $83.0M
Depreciation $43.9M $56.2M $57.7M $61.0M $62.9M $62.5M $61.7M $56.4M
Amortization $7.1M $12.3M $11.9M $9.7M $11.7M $9.8M $13.4M $18.3M
Stock-Based Compensation $24.1M $14.8M $15.6M $12.4M $23.2M $24.1M $9.9M $26.6M
Net Cash from Operating Activities $80.3M $111.7M $118.6M $108.1M $141.6M $379.1M $177.9M $202.7M
Investing Activities
Capital Expenditures $34.3M $41.6M $58.5M $59.1M $68.6M $63.8M $66.1M $70.4M
Business Acquisitions $0 $0 $77.3M $0 $19.0M $14.9M $8.1M $38.5M
Net Cash from Investing Activities $170.7M $-38.0M $-134.5M $-67.1M $-88.7M $-79.4M $-71.4M $-108.8M
Financing Activities
Dividends Paid $11.8M $11.9M $77.6M $77.0M $76.3M $78.4M $82.2M $80.6M
Stock Repurchases $20.0M $0 $13.0M $70.0M $80.4M $144.3M $825.0K $69.6M
Net Cash from Financing Activities $-202.4M $-133.2M $10.7M $-99.5M $-104.7M $-245.2M $-154.8M $-116.7M
Net Change in Cash $51.7M $-69.2M $-8.7M $-74.9M $-63.1M $67.1M $-51.3M $-39.5M
Free Cash Flow $46.0M $70.2M $60.1M $49.0M $73.0M $315.3M $111.9M $132.4M
← Newer Page 1 of 3 Older →